(Q44489597)

3 December 2017

title

Synthesis and structure-activity relationships of open D-Ring galanthamine analogues (English)

1 reference

3 December 2017

Denyse Herlem

1

1 reference

3 December 2017

Marie Thérèse Martin

series ordinal

2

1 reference

3 December 2017

Claude Thal

series ordinal

3

1 reference

3 December 2017

Catherine Guillou

series ordinal

4

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

3 December 2017

published in

1 reference

3 December 2017

volume

13

1 reference

3 December 2017

issue

14

1 reference

3 December 2017

page(s)

2389-2391

1 reference

The pharmacology of galanthamine and its analogues

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

Alkaloid N-oxides from Lycoris sanguinea

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

Peripheral binding site is involved in the neurotrophic activity of acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

The adhesion function on acetylcholinesterase is located at the peripheral anionic site

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

Molecular modeling of the amyloid-beta-peptide using the homology to a fragment of triosephosphate isomerase that forms amyloid in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

Alzheimer's disease: the amyloid cascade hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900397-4

7 January 2021

10.1016/S0960-894X(03)00397-4

Identifiers

DOI

1 reference

3 December 2017

1 reference